Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/Explore/US Market Price/Stocks/NVO
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

Novo Nordisk A/S (NVO) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

Novo Nordisk (NVO) trades at $49.68, down 1.27% on the day, amid a bullish technical signal from moving averages. The company demonstrates robust fundamentals with a trailing P/E of 12.08 and a net income margin of 37.2%, supported by three consecutive quarterly earnings beats. Recent positive catalysts include EU and Indian regulatory approvals for its oral Wegovy weight-loss pill, expanding its GLP-1 franchise.
The outlook remains positive given strong analyst consensus (57.9% Buy ratings) and projected earnings growth, though risks include intensifying competition in the weight-loss drug market and potential margin pressure. The stock presents a compelling opportunity for investors seeking exposure to a profitable leader in metabolic diseases.
Read full analysis

Key Stats

  • Market Cap
    $220.53B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $71.70
  • 52W Low
    $35.29
  • Typical Hold Time
    -
  • Enterprise Value
    $239.49B
  • Div Yield
    3.63%
  • Trading Activity
    -
$49.39
52W Low: $35.29
30 Mar 2026
52W High: $71.7
25 Jul 2025

Track Novo Nordisk A/S (NVO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Novo Nordisk A/S has traded between a low of $35.29 and a high of $71.7, highlighting its annual price range. Buy and sell Novo Nordisk A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Most Recent News

Content is generated by Aura AI

Global operating costs surge in Q2 amid Middle East conflict, but economic confidence shows slight recovery.

The Q2 2026 Global Economic Conditions Survey by ACCA and IMA reveals a sharp rise in operating costs for accountants and CFOs worldwide, driven by the Middle East conflict, soaring commodity prices, and supply chain issues. Over 75% of accountants a...

Market News
1 hour ago
Acca And Ima
Bearish
news icon
pluang ai news

Zoom appoints Carlos Quaderi as Head of APAC to lead AI-driven growth phase

Zoom Video Communications has appointed Carlos Quaderi as Head of Asia Pacific (APAC), effective August 1, 2026. Quaderi will oversee Zoom's go-to-market strategy across APAC, including Australia, New Zealand, Asia, India, and Korea (excluding Japan)...

Market News
3 hours ago
Hayley Yap
Bullish
news icon
pluang ai news

AerCap orders 15 more Boeing 787s powered by GE's reliable GEnx engines

AerCap has selected GE Aerospace's GEnx-1B engines to power 15 additional Boeing 787 Dreamliners, reinforcing its position as the largest owner of these aircraft. The GEnx engine is known for its high reliability, with a 99.98% dispatch rate and exte...

Market News
4 hours ago
GlobeNewsWire
Bullish
news icon
pluang ai news
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $220.53B
  • Volume
    -
  • Sector
    Health
  • 52W High
    $71.70
  • 52W Low
    $35.29
  • Typical Hold Time
    -
  • Enterprise Value
    $239.49B
  • Div Yield
    3.63%
  • Trading Activity
    -
$49.39
52W Low: $35.29
30 Mar 2026
52W High: $71.7
25 Jul 2025

Track Novo Nordisk A/S (NVO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Novo Nordisk A/S has traded between a low of $35.29 and a high of $71.7, highlighting its annual price range. Buy and sell Novo Nordisk A/S shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!